03/31/2024
11:15 PM | Adverum Biotechnologies (Filer)
| Form EFFECT | |
03/26/2024
11:15 PM | Adverum Biotechnologies (Filer)
| Form EFFECT | |
03/21/2024
4:24 PM | Adverum Biotechnologies (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/20/2024
4:04 PM | Adverum Biotechnologies (Filer)
| Form 424B3 | |
03/20/2024
3:13 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
6:05 PM | Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:06 PM | Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/12/2024
6:07 PM | Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:40 PM | Adverum Biotechnologies (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/22/2024
2:47 PM | Adverum Biotechnologies (Subject)
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Logos Global Management LP (Filed by)
| Form SC 13G | |
02/21/2024
2:39 PM | Adverum Biotechnologies (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/15/2024
3:17 PM | Adverum Biotechnologies (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
02/14/2024
7:26 PM | Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024
6:34 PM | Adverum Biotechnologies (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
| Form SC 13G/A | |
02/12/2024
9:13 AM | Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
02/09/2024
4:50 PM | Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:51 PM | Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:35 AM | Adverum Biotechnologies (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
7:45 AM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
10:36 AM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/06/2024
3:47 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
6:54 PM | Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
6:52 PM | Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2023
3:10 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
5:54 PM | Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:14 PM | Adverum Biotechnologies (Issuer)
Rubinstein Linda M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:16 PM | Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
06/13/2023
5:19 PM | Adverum Biotechnologies (Issuer)
Ozden Rabia Gurses (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:17 PM | Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:02 PM | Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:03 PM | Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:05 PM | Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:10 PM | Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:13 PM | Adverum Biotechnologies (Issuer)
Tuckson Reed Vaughn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:15 PM | Adverum Biotechnologies (Issuer)
Whitcup Scott M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2023
5:29 AM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2023
11:15 PM | Adverum Biotechnologies (Filer)
| Form EFFECT | |
04/25/2023
4:21 PM | Adverum Biotechnologies (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
